The trademark application APEXp was filed by TELUM THERAPEUTICS S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on October 18, 2021, and it was registered by office on March 1, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1627525 at the World Intellectual Property Organization (WIPO).
The application was filed in Spanish (English was selected as the second language).
Relative errors of the trademark registration was recorded on March 30, 2022.
Goods And Services
The mark was filed in class 9 with following description of goods:
Software for research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Computer software platforms for research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Artificial intelligence software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Artificial intelligence software platforms for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria.
The mark was filed in class 42 with following description of goods:
Software as a service [SaaS] featuring software for research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Software as a service [SaaS] featuring artificial intelligence software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Platform as a service [PaaS] featuring software for research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Platform as a service [PaaS] featuring artificial intelligence software platforms for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Biomedical research services
Scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria
Research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Clinical trials of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria.